Journal article icon

Journal article

Diagnostic accuracy, treatment and prognosis of myocardial infarction: an 11-year follow-up of a community-based cohort of 0.5 million Chinese adults

Abstract:
Background: Myocardial infarction (MI) is a major cause of premature death and disability in China, but available data on diagnostic accuracy, treatment and prognosis of MI cases remain limited.
Methods: The China Kadoorie Biobank enrolled 512,000 adults (mean age 51 years, 59% women) from 10 (5 urban, 5 rural) areas between 2004-2008. Medical records were sought on 37,159 reported first incident ischaemic heart disease (IHD) cases occurring before 2018 for adjudication. Diagnostic accuracy and risks of recurrent MI, stroke, heart failure and allcause mortality were assessed for reported and adjudicated cases of MI and all IHD.
Results: Among 19,135 adjudicated IHD cases, 10.2% (n=1,948) had MI, with diagnostic accuracy of 98% for MI and 93% for all IHD. Use of guideline-directed (antiplatelet, lipidlowering, antihypertensive, and anticoagulant) medications in hospital was high (93% MI; 83% all IHD), but differed by hospital tier and area. Use of coronary revascularisation was low (39% MI; 10% all IHD), even in higher tier hospitals. The 28-day case-fatality was 6-fold greater for MI than all IHD (12.0% vs 2.0%), and higher in older cases and in women, residents in rural areas, but comparable by hospital tier. Disparities in 5-year mortality rates persisted for both MI and all IHD, by age, sex, area and hospital tiers.
Conclusions: This large community-based prospective study demonstrated high levels of diagnostic accuracy for MI and all IHD in Chinese adults, but also identified disparities in treatment and outcomes that should be prioritised in future prevention strategies.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1136/bmjph-2025-004019

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Clinical Trial Service Unit
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Clinical Trial Service Unit
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Clinical Trial Service Unit
Role:
Author
ORCID:
0000-0002-3946-1870
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Clinical Trial Service Unit
Role:
Author


More from this funder
Funder identifier:
https://ror.org/029chgv08
Grant:
104085/Z/14/Z
212946/Z/18/Z
202922/Z/16/Z
More from this funder
Funder identifier:
https://ror.org/03x94j517
Grant:
MC_U137686851
MC_UU_12026/2
MC_UU_00017/1


Publisher:
BMJ Publishing Group
Journal:
BMJ Public Health More from this journal
Volume:
4
Issue:
1
Article number:
e004019
Publication date:
2026-03-10
Acceptance date:
2026-02-18
DOI:
EISSN:
2753-4294
ISSN:
2753-4294


Language:
English
Keywords:
Pubs id:
2384209
Local pid:
pubs:2384209
Source identifiers:
W7134884197
Deposit date:
2026-03-03
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP